# Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism

> **NCT01572259** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 40 (estimated)

## Conditions studied

- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** Growth Hormone
- **OTHER:** interruption of the traitment with growth hormone

## Key facts

- **NCT ID:** NCT01572259
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2016-03
- **Final completion:** 2017-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01572259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01572259, "Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01572259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*